Renal Disease Market Widespread Research and Fundamental Study Focusing on Innovative Treatments During the Period Until 2023

A fresh report has been added to the wide database of Market Research Future titled “Global Renal Disease Market Research Report - Forecast to 2023” by Treatments, Countries, Disease Type and Application, Forecast to 2023 which provides important data about the revenue and company profiles

Most Renal Diseases attack the nephrons. This damage may leave kidneys unable to remove wastes. Causes can include genetic problems, injuries, or medicines. Diabetics and high blood pressure patients have a higher risk of kidney disease. Chronic Renal disease damages the nephrons slowly over several years. The Global Renal Disease Market is expected to register a CAGR of 6.32% to reach USD 93,375.70 million till 2023.

A recent study also emphasizes on Air pollution that could harm your kidneys. People with Renal Diseases are at increased risk of developing a life-threatening abnormal heart rhythm, a new report suggests. Chronic Renal disease can as much as double a patient's risk of atrial fibrillation, a quivering or irregular heartbeat that can lead to stroke or heart failure. The risk of atrial fibrillation increases as kidney function declines.

Get Free Sample @

With the number of kidney failure patients expected to continue to rise in the future, healthcare providers are seeking new ways to expand treatment options, improve outcomes, and reduce the chronic health conditions that contribute to the potentially deadly disease.

Kidney transplants which can be performed using a kidney from a deceased donor or an organ from a living donor, if certain biological factors can be matched are only part of the picture. Efforts to find desperately needed donors, both living and dead, can only go so far, and the use of dialysis as a stopgap measure is far from optimal. Despite significant improvements in the surgery and new techniques that allow far more options for matching living donors, there is a significant shortage of available kidneys. As a result, doctors are now looking to stop kidney disease before it starts.

Renal Disease Market – Major Players

There are plenty of large and small market players which operate in this market:

Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals, Inc. (US)
NephroGenex, Inc. (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)

Renal Disease Market - Segmentation

The Renal Disease Market is segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

Segmentation By Types: Comprises Acute Kidney Problems, Chronic Kidney Diseases, and other.

Segmentation By Diagnosis: Comprises Blood tests, Urine tests, Imaging tests, Removing a sample of kidney tissue for testing, and other.

Segmentation By Treatment: Comprises Medications, Dialysis, Kidney transplant, Surgery, Diet and others.

Segmentation By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Renal Disease Market - Regional Analysis

Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover, the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the Global Renal Disease Market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.

A vague statistic indicates that 30 million American adults are likely to have chronic kidney disease, and most aren't aware of it. 1 in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history of kidney failure. People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease. African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end stage renal disease.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Release ID: 526033